(Q71704041)

inferred from SMILES

chemical formula

C₁₉H₂₁NO

1 reference

inferred from SMILES

canonical SMILES

CN(C)CCC=C1c2ccccc2COc2ccccc21

1 reference

significant drug interaction

inferred from InChI

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nebivolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

geniospasm

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperthermia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-nefopam

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

allomnesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

hypotonia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

SINEquan

Institute for Safe Medication Practices

subject named as

Sinequan

1 reference

reference URL

https://www.ismp.org/recommendations/tall-man-letters-list

retrieved

2 September 2022

Commons category

Doxepin

0 references

Identifiers

InChI

InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3

0 references

0 references

CAS Registry Number

1668-19-5

1 reference

https://commonchemistry.cas.org/detail?cas_rn=1668-19-5

9 April 2021

0 references

1 reference

ChEBI ID

4710

mapping relation type

exact match

2 references

ChEBI release 2021-03-01

International Chemical Identifier

InChI

InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3

SureChEMBL ID

SCHEMBL28054

2 references

inferred from InChIKey

splash10-053r-3890000000-67a52c632bae37e353c8

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

HSDB ID

3069

1 reference

Hazardous Substances Data Bank

28 October 2019

DOXEPIN (English)

10 May 2021

1 reference

AICS Chemical ID (BEING DELETED)

0 references

0 references

Doxepin

0 references

0 references

0 references

1 reference

26 February 2018

1 reference

language of work or name

Doxepin (English)

18 November 2016

1 reference

Human Metabolome Database ID

HMDB0015273

2 references

inferred from InChIKey

MedlinePlus drug identifier

a682390

route of administration

oral administration

medical condition treated

mental depression

anxiety

0 references

a617017

route of administration

oral administration

medical condition treated

insomnia

0 references

a605040

route of administration

0 references

1 reference

language of work or name

DOXEPIN (English)

19 January 2016

0 references

1 reference

0 references

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

language of work or name

3RZE (English)

19 October 2016

0 references

0 references

WordNet 3.1 Synset ID

03234608-n

1 reference